Beijing Kawin Technology Share-Holding Co., Ltd. (688687.SS) SHH
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Beijing Kawin Technology Share-Holding Co., Ltd.
Address
Building 3, No. 6, Rongjing East Street
Beijing, BE 100176
China
Phone
86 10 6789 2271
Website
Sector
Healthcare
Industry
Biotechnology
Employees
584
First IPO Date
February 08, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Jifeng Shi | Vice President, Chief Research Officer, Core Technical Personnel & Director | 0 | 1974 |
| Xiao Xu | Vice President | 0 | 1974 |
| Shan Liu | Head of Antibody Drug Development Department & Core Technical Personnel | 0 | 1988 |
| Huan Wang | Executive Vice President & Director | 0 | 1979 |
| Jian Tang | Vice President | 0 | 1978 |
| Desheng Zhou | President & Chairman of the Board | 0 | 1971 |
| Xiang Li | Manager of Information Strategy Research Department & Core Technical Personnel | 0 | 1983 |
| Lu Yang | Deputy GM of Beiyi Protein Drug R&D and Core Technical Personnel | 0 | 1983 |
| Chongfei He | Vice President, Secretary to the Board & Chief Financial Officer | 0 | 1969 |
| Zhenqiang Du | Vice President | 0 | 1976 |
Description
Established in 2008 and based in Beijing, China, Beijing Kawin Technology Share-Holding Co., Ltd. specializes in the research, development, and manufacturing of pharmaceutical products, with a primary emphasis on treatments for liver conditions within the Chinese market. Its key offerings include recombinant human interferon alfa-2b injection and compound glycyrrhizin. Beyond its own product line, the company supplies active pharmaceutical ingredients (APIs) and delivers comprehensive clinical research services for advancing biological products. These services encompass the fermentation and purification of drug substances, drug product formulation, and the creation of analytical methods. Beijing Kawin also offers contract manufacturing solutions. The company's global footprint includes serving customers in countries such as Pakistan, Colombia, the Philippines, Vietnam, Russia, and Cambodia, among others. Furthermore, it maintains strategic partnerships with entities like Legend Capital, Haitong Capital, and Cybernaut.
